# US 2024/0189594 A1 · Auricular device for nerve stimulation and methods of operating same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189594 A1
- Document ID: US20240189594A1
- Status: Published application
- Kind: A1
- Application number: 18/554,914
- Filed: 2022-04-14
- Published: 2024-06-13
- Earliest claimed: 2021-04-16
- Assignees: Cala Health, Inc.
- Applicants: Cala Health, Inc.
- Inventors: Samuel Richard HAMNER; Alexander R. KENT; Kathryn H. ROSENBLUTH; Mark SHUGHART; Jonas LAGERSTEDT; Gregory T. SCHULTE; Jessica M. LIBERATORE
- Web page: https://patentgrep.com/patent/US20240189594A1

## CPC

- A61N 1/36036: {of the outer, middle or inner ear}
- A61N 1/025: {Digital circuitry features of electrotherapy devices, e.g. memory, clocks, processors}
- A61N 1/0456: {Specially adapted for transcutaneous electrical nerve stimulation [TENS]}
- A61N 1/0472: {Structure-related aspects}
- A61N 1/36014: {External stimulators, e.g. with patch electrodes (external pacemakers A61N1/3625)}
- A61N 1/36031: {using physiological parameters for adjustment}
- A61N 1/36034: {specified by the stimulation parameters}
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61N 2007/0026: {Stimulation of nerve tissue}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

An auricular device for noninvasive nerve stimulation can include a first portion configured to secure within an ear canal of a user and a second portion coupled with the first portion and configured to be placed within an car such as within the concha cymba. The second portion can include a nerve effector for modulation of (including but not limited to providing electrical stimulation to) a vagal nerve of the user. A hardware processor can generate a stimulation waveform that is gradual upon every stimulation burst. The second portion can include a first and second prong and the first portion can include an ear canal element. The auricular device can include a stem connected to the prongs, active and return electrodes coupled to the prongs, and a boss coupling the stem and the ear canal element together. The boss can allow the ear canal element and stem to rotate and move relative to one another.

## Claims

### Claim 1

An auricular device for noninvasive vagal nerve neuromodulation employing a gradual stimulation burst pattern, the auricular device comprising:
a first portion configured to secure at least partially within an ear canal of a user;
a second portion coupled with the first portion and configured to be placed within the concha cymba of an ear of the user when the first portion is at least partially secured within the ear canal of the user; and
one or more hardware processors configured to generate the gradual stimulation burst pattern,
wherein the gradual stimulation burst pattern comprises a lower stimulation intensity that gradually increases to a higher intensity,
wherein the second portion comprises a nerve effector configured to apply the gradual stimulation burst pattern so as to modulate a vagal nerve of the user.

### Claim 2 (depends on 1)

The auricular device of claim 1,
further comprising a third portion having a stem and a boss,
wherein the first portion comprises an ear canal element,
wherein the stem is slidably connected to the boss and rotatably connected to the ear canal element via the boss; and
wherein the nerve effector comprises one or more electrodes.

### Claim 3 (depends on 1)

The auricular device of claim 1,
wherein the nerve effector comprises a first electrode and a second electrode,
wherein the first electrode comprises an active electrode, and
wherein the second electrode comprises a return electrode.

### Claim 4 (depends on 3)

The auricular device of claim 3, wherein the active and return electrodes are spaced apart from one another by a distance that is between 10 mm and 15 mm.

### Claim 5 (depends on 3)

The auricular device of claim 3, further comprising a first prong and a second prong,
wherein each of the first and second prongs comprises a first end connected to the stem and a second end opposite the first end,
wherein the active electrode is positioned at the second end of the first prong, and
wherein the return electrode is positioned at the second end of the second prong.

### Claim 6 (depends on 5)

The auricular device of claim 5, wherein the first and second prongs are configured to allow each of the active and return electrodes to simultaneously make independent contact with portions of the concha cymba.

### Claim 7 (depends on 6)

The auricular device of claim 6, wherein the first and second prongs are configured to exert a force on the concha cymba, wherein said force is between 0.01 N and 1 N.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The auricular device of any of claims 1-7, wherein the lower stimulation intensity gradually increases to the higher intensity over a plurality of pulses of the gradual stimulation burst pattern.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7)

The auricular device of any of claims 1-7, wherein the lower stimulation intensity gradually increases to the higher intensity over an initial pulse of the gradual stimulation burst pattern.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7)

The auricular device of any of claims 1-7, further comprising one or more sensors selected from the group consisting of a Photoplethysmography sensor (PPG), a galvanic skin sensor (GSR), an inertial measurement unit sensor (IMU), temperature sensor, and an Electroencephalography sensor (EEG), wherein the one or more hardware processors are further configured to modify the gradual stimulation burst pattern based on one or more physiological parameters determined from the one or more sensors.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7)

The auricular device of any of claims 1-7, wherein an addition nerve is stimulated in addition to the vagal nerve.

### Claim 12 (depends on 2)

The auricular device of claim 2, wherein the boss is configured to move relative to the stem while coupled with the stem and the ear canal element.

### Claim 13 (depends on 2)

The auricular device of claim 2, wherein the boss comprises a pocket configured to receive the stem.

### Claim 14 (depends on 13)

The auricular device of claim 13, wherein said pocket surrounds a portion of a perimeter of a cross-section of the stem when the boss is coupled with the stem.

### Claim 15 (depends on 13, 14)

The auricular device of claim 13 or 14, wherein said pocket comprises a protrusion and wherein said stem comprises one or more notches recessed from a surface of the stem, the one or more notches configured to receive at least a portion of the protrusion.

### Claim 16 (depends on 15)

The auricular device of claim 15, wherein said one or more notches comprises a plurality of notches.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7)

The auricular device of any of claims 1-7, wherein the gradual stimulation burst pattern comprises a pulse rate of from 1 Hz to 20 KHz.

### Claim 18 (depends on 17)

The auricular device of claim 17, wherein the gradual stimulation burst pattern comprises a pulse rate of from 1 kHz to 20 KHz.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7)

The auricular device of any of claims 1-7, wherein the gradual stimulation burst pattern comprises a pulse width from 50 to 500 μs.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7)

The auricular device of any of claims 1-7, wherein the gradual stimulation burst pattern comprises an intensity from 0 mA to 500 mA.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7)

The use of the auricular device of any of claims 1-7 to treat inflammation.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7)

The use of the auricular device of any of claims 1-7 to treat tremor.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7)

The use of the auricular device of any of claims 1-7 to stimulate one or more of the following: a trigeminal nerve, a greater auricular nerve, a nerve of the auricular branch, an auricular branch of the vagus nerve, a facial nerve, and an auriculotemporal nerve.

### Claim 24 (depends on 5, 6, 7)

The auricular device of any of claims 5-7, wherein at least one of the first and second prongs are flexible and/or resilient.

### Claim 25 (depends on 5, 6, 7)

The auricular device of any of claims 5-7, wherein only one of the first and second prongs are flexible and/or resilient.

### Claim 26 (depends on 5, 6, 7)

The auricular device of any of claims 5-7, wherein both of the first and second prongs are flexible and/or resilient.

### Claim 27 (depends on 5, 6, 7)

The auricular device of any of claims 5-7, wherein the second ends of the first and second prongs are spaced away from one another.

### Claim 28 (depends on 26)

The auricular device of claim 26, wherein the second ends of the first and second prongs are spaced away from one another by a distance that is between approximately 10 mm and approximately 15 mm.

### Claim 29 (depends on 3, 4, 5, 6, 7)

The auricular device of any of claims 3-7, wherein a diameter of an electrode-skin contact surface area of each of the active and return electrodes is between approximately 2 mm and approximately 8 mm.

### Claim 30 (depends on 28)

The auricular device of claim 28, wherein said diameter of said electrode-skin contact surface area of each of the active and return electrodes is approximately 4 mm.

### Claim 31 (depends on 5, 6, 7)

The auricular device of any of claims 5-7, wherein the first and second prongs are angled with respect to one another at an angle between approximately 20° and approximately 90°.

### Claim 32 (depends on 5, 6, 7)

The auricular device of any of claims 5-7, wherein the first prong has a greater length than the second prong.

### Claim 33 (depends on 5, 6, 7)

The auricular device of any of claims 5-7, wherein the second prong has a greater length than the first prong.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The auricular device of any of claims 1-33, further comprising a power source configured to provide power to the nerve effector.

### Claim 35 (depends on 2)

The auricular device of claim 2, wherein the stem is rigid.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The auricular device of any of claims 1-35, wherein the auricular device is configured to electrically connect to a power source separate from the auricular device.

### Claim 37

An auricular device for noninvasive vagal nerve neuromodulation, the auricular device comprising:
an ear canal element configured to secure at least partially within an ear canal of a user;
a boss rotatably coupled with the ear canal element;
a stem slidably coupled to the boss and rotatable relative to the ear canal element via the boss;
at least one prong coupled to the stem; and
a nerve effector coupled to an end of the at least one prong,
wherein the stem and the at least one prong are configured to position the nerve effector within the concha cymba of the ear of the user when the ear canal element is at least partially secured within the ear canal of the user.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The auricular device of any of claims 1-37, wherein the auricular device does not include a hydrogel material adjacent the active electrode.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The auricular device of any of claims 1-38, wherein the auricular device does not include a hydrogel material adjacent the return electrode.

### Claim 40 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The auricular device of any of claims 1-39, wherein the auricular device does not include an adhesive material adjacent the active electrode.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The auricular device of any of claims 1-40, wherein the auricular device does not include an adhesive material adjacent the return electrode.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The auricular device of any of claims 1-41, wherein the auricular device does not include any percutaneous components.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The auricular device of any of claims 1-42, wherein the auricular device does not include any implantable components.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The auricular device of any of claims 1-43, wherein the auricular device does not include a cable.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The auricular device of any of claims 1-44, wherein the auricular device does not include a battery.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The auricular device of any of claims 1-44, wherein the auricular device includes a battery.

### Claim 47

A system for controlling an auricular device, the system comprising one or more hardware processors configured to:
generate a stimulation waveform for stimulation with one or more electrodes, wherein the stimulation waveform comprises a gradual burst pattern; and
apply the stimulation waveform to the one or more electrodes.

### Claim 48 (depends on 47)

The system of claim 47, wherein the one or more hardware processors are further configured to modify the stimulation waveform based on one or more physiological parameters determined from a physiological sensor selected from the group consisting of a Photoplethysmography sensor (PPG), a galvanic skin sensor (GSR), and an Electroencephalography sensor (EEG).

### Claim 49 (depends on 47, 48)

The system of claim 47 or 48, wherein the one or more hardware processors are further configured to modify the stimulation waveform based on data determined from an inertial measurement unit sensor (IMU).

### Claim 50

A method of modulating one or more nerves of a subject, the method comprising:
generating, with one or more hardware processors, a stimulation waveform for stimulation with one or more electrodes, wherein the stimulation waveform comprises a gradual burst pattern; and
applying the stimulation waveform to a portion of the subject's body with the one or more electrodes to stimulate said one or nerves.

### Claim 51 (depends on 50)

The method of claim 50, wherein said one or more nerves comprises two or more of the following:
a vagus nerve, a greater auricular nerve, and a trigeminal nerve.

### Claim 52 (depends on 50)

The method of claim 50, wherein said one or more nerves comprises only one of the following: a vagus nerve, a greater auricular nerve, and a trigeminal nerve.

### Claim 53 (depends on 50, 51, 52)

The method of any of claims 50-52, further comprising:
determining one or more physiological parameters of the subject using a physiological sensor; and
modifying the stimulation waveform based on said one or more physiological parameters.

### Claim 54 (depends on 50, 51, 52)

The method of any of claims 50-52, further comprising:
determining motion data of the subject with an inertial measurement unit sensor (IMU); and
modifying the stimulation waveform based on said motion data.

### Claim 55 (depends on 53)

The method of claim 53, wherein said physiological sensor comprises a Photoplethysmography sensor (PPG).

### Claim 56 (depends on 53)

The method of claim 53, wherein said physiological sensor comprises a galvanic skin sensor (GSR).

### Claim 57 (depends on 53)

The method of claim 53, wherein said physiological sensor comprises an Electroencephalography sensor (EEG).

### Claim 58

A method of noninvasively modulating a vagal nerve of a subject, the method comprising:
positioning a neuromodulation device proximate an ear of the subject, said neuromodulation device comprising a first portion and a second portion coupled with said first portion, wherein said second portion comprises a nerve effector;
securing the first portion at least partially within an ear canal of the subject; and
modulating the vagal nerve of the subject with the nerve effector of the neuromodulation device.

### Claim 59 (depends on 58)

The method of claim 58, wherein said nerve effector comprises at least one electrode and wherein said modulating the vagal nerve of the subject comprises stimulating the vagal nerve with said at least one electrode.

### Claim 60 (depends on 58)

The method of claim 58, wherein said nerve effector comprises at least a first and second electrode.

### Claim 61 (depends on 60)

The method of claim 60, wherein said first electrode comprises an active electrode and said second electrode comprises a return electrode.

### Claim 62 (depends on 58, 59, 60, 61)

The method of any of claims 58-61, wherein:
said first portion comprises an ear canal element;
said second portion comprises at least one prong configured to operably position the nerve effector within a portion of the ear of the subject;
said neuromodulation device further comprises a stem connecting the ear canal element to the at least one prong; and
said method further comprises adjusting a position of the ear canal element relative to the stem.

### Claim 63 (depends on 62)

The method of claim 62, wherein said adjusting the position of the ear canal element relative to the stem comprises moving the ear canal element along a portion of a length of the stem.

### Claim 64 (depends on 62, 63)

The method of claim 62 or 63, wherein said neuromodulation device further comprises a boss configured to couple the ear canal element to the stem and allow the ear canal element to move along the portion of the length of the stem.

### Claim 65 (depends on 62, 63, 64)

The method of any of claims 62 to 64, wherein said ear canal element is rotatably coupled to the stem and wherein said adjusting the position of the ear canal element relative to the stem comprises rotating the ear canal element.

### Claim 66 (depends on 62, 63)

The method of claim 62 or 63, wherein said neuromodulation device further comprises a boss configured to rotatable couple the ear canal element to the stem and allow the ear canal element to rotate while coupled to the stem.

### Claim 67 (depends on 58, 59, 60, 61, 62, 63, 64, 65, 66)

The method of any of claims 58-66, further comprising positioning the nerve effector within a concha cymba of the ear of the subject.

### Claim 68 (depends on 67)

The method of claim 67, wherein said modulating the vagal nerve of the subject with said nerve effector comprises applying electrical stimulation to the concha cymba of the ear of the subject.

### Claim 69 (depends on 67, 68)

The method of claim 67 or 68, wherein said nerve effector comprises a first electrode and a second electrode, and wherein said method further comprises positioning said first and second electrodes against the concha cymba and spaced apart from one another by a distance.

### Claim 70 (depends on 69)

The method of claim 69, wherein said distance is between approximately 10 mm and approximately 15 mm.

### Claim 71 (depends on 67, 68, 69, 70)

The method of any of claims 67-70, further comprising applying a force on the concha cymba of the ear of the subject with the nerve effector.

### Claim 72 (depends on 71)

The method of claim 71, wherein said force is between approximately 0.01 N and approximately 1 N.

### Claim 73 (depends on 1)

The auricular device of claim 1, wherein the vagal nerve is down regulated.

### Claim 74 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The use of any one of the devices of claims 1-49, wherein the neuromodulation of the vagal nerve: affects neurotransmitter release, uptake and/or metabolism; increases neurotransmitter release, uptake and/or metabolism; decreases neurotransmitter release, uptake and/or metabolism; balances neurotransmitter release, uptake and/or metabolism by both increasing and decreasing neurotransmitter activity; activates or down regulates the dopaminergic system; activates or down regulates the serotonergic system; regulates the brain-gut axis; treats depression (including but not limited to post-partum depression, depression affiliated with neurological diseases, major depression, seasonal affective disorder, depressive disorders, etc.); treats inflammation (e.g., neuroinflammation); treats Lyme disease; treats stroke; treats neurological diseases (such as Parkinson's and Alzheimer's); treats gastrointestinal issues (including those in Parkinson's disease); treats inflammatory bowel disease (such as Crohn's disease, colitis, and functional dyspepsia), rheumatoid arthritis, multiple sclerosis, psoriatic arthritis, osteoarthritis, psoriasis and other inflammatory diseases; treats inflammatory skin conditions; treats chronic fatigue syndrome; treats chronic inflammatory symptoms and flare ups; treats cardiac conditions (such as atrial fibrillation, hypertension, epilepsy, and stroke); treats immune dysfunction; stimulates the autonomic nervous system; balance the sympathetic/parasympathetic nervous systems; treats habituation; treats mood disorders; treats pain (e.g., back pain, joint pain, stiffness, muscle pain, tension); treats pain syndromes (e.g., trigeminal neuralgia, fibromyalgia, complex regional pain syndrome); treats microbial Infections (e.g., bacteria, viruses, fungi, and parasites); treats tetanus; treats meningitis; treats urinary tract infection; treats mononucleosis; treats autoimmune disorders; treats bradykinesia; treats dyskinesia; treats Gait dysfunction; treats dystonia; treats rigidity; treats hypertension; treats tinnitus; and/or treats dexterity.

### Claim 75 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The use of any one of the devices of claims 1-49 in a system and/or method which further comprises a wrist worn device.

### Claim 76 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The use of any one of the devices of claims 1-49 in a system and/or method which stimulates one or more of a vagus nerve, trigeminal nerve, greater auricular nerve, nerves of the auricular branch, auricular branch of the vagus nerve, a facial nerve, an auriculotemporal nerve, or other nerve near the ear to modulate vasodilation or vasoconstriction.

### Claim 77

An auricular device for noninvasive vagal nerve neuromodulation employing a stimulation burst pattern, the auricular device comprising:
a first portion configured to secure at least partially within an ear canal of a user;
a second portion coupled with the first portion and configured to be placed within the concha cymba of an ear of the user when the first portion is at least partially secured within the ear canal of the user; and
one or more hardware processors configured to generate the stimulation burst pattern,
wherein the second portion comprises a nerve effector configured to apply the stimulation burst pattern so as to modulate a vagal nerve of the user.

### Claim 78 (depends on 77)

The auricular device of claim 77, wherein the stimulation burst pattern comprises a lower stimulation intensity that increases to a higher intensity.
